Synonyms: Example 9 [WO2013107283A1]
Compound class:
Synthetic organic
Comment: We obtained the chemical structure for tunlametinib from WHO Proposed list 125 (July 2021). This mapped to PubChem CID 71621329. The chemical structure is claimed in Tianjin Binjiang Pharma's patent WO2013107283A1 for activity as a MEK inhibitor with potential to treat cancers and inflammation [1].
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
4-fluoro-5-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1,3-benzothiazole-6-carboxamide |
International Nonproprietary Names | |
INN number | INN |
11753 | tunlametinib |
Synonyms |
Example 9 [WO2013107283A1] |
Database Links | |
CAS Registry No. | 1801756-06-8 (source: WHO INN record) |
GtoPdb PubChem SID | 442878701 |
PubChem CID | 71621329 |
Search Google for chemical match using the InChIKey | UFZJUVFSSINETF-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | UFZJUVFSSINETF |
Search PubMed clinical trials | tunlametinib |
Search PubMed titles | tunlametinib |
Search PubMed titles/abstracts | tunlametinib |
UniChem Compound Search for chemical match using the InChIKey | UFZJUVFSSINETF-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UFZJUVFSSINETF-UHFFFAOYSA-N |